Sweden and Denmark have suspended vaccination with Moderna in people under 30

The Public Health Authority (FHM), in charge of the vaccination campaign, “has decided to suspend the use of Moderna’s Spikevax vaccine for all people born after 1991, as a precautionary principle,” she said. in a press release.

This decision is taken “after signs of increased risk of side effects such as inflammation of the myocardium and pericardium”, specifies the FHM.

According to the agency, the risk is higher after the second dose and in men. “The risk is minimal, it’s a very rare side effect,” he says.

“Myocarditis and pericarditis usually go away on their own, without causing lasting problems, but symptoms should be evaluated by a doctor,” the agency explains.

“In preliminary data, there is a suspicion of an increased risk of heart inflammation, when vaccinated with Moderna,” they told the Danish Health Authority.

About 81,000 people under the age of 30 received the first dose of Moderna in Sweden, not the second.

In July, the European Medicines Agency extended its authorization of the Moderna vaccine to adolescents aged 12 to 17.

In Norway, the infection control officer for The Norwegian Institute of Public Health has also asked to avoid the Moderna vaccine in those under 30 years old. “Men under 30 should also consider choosing Pfizer when getting vaccinated.” Geir Bukholm said in a statement.